DK240089A - Fremgangsmaade til udvinding af et proeveantigen til diagnosticering af infektion med bovint herpesvirus - Google Patents

Fremgangsmaade til udvinding af et proeveantigen til diagnosticering af infektion med bovint herpesvirus

Info

Publication number
DK240089A
DK240089A DK240089A DK240089A DK240089A DK 240089 A DK240089 A DK 240089A DK 240089 A DK240089 A DK 240089A DK 240089 A DK240089 A DK 240089A DK 240089 A DK240089 A DK 240089A
Authority
DK
Denmark
Prior art keywords
infection
virus
bovint
diagnostication
herpesvirus
Prior art date
Application number
DK240089A
Other languages
English (en)
Other versions
DK240089D0 (da
Inventor
Hans-Joachim Bengelsdorff
Eckhard Koschel
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK240089D0 publication Critical patent/DK240089D0/da
Publication of DK240089A publication Critical patent/DK240089A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16751—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK240089A 1988-05-18 1989-05-17 Fremgangsmaade til udvinding af et proeveantigen til diagnosticering af infektion med bovint herpesvirus DK240089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3816885A DE3816885A1 (de) 1988-05-18 1988-05-18 Verfahren zur gewinnung eines testantigens fuer die diagnose der bovinen herpesvirus typ 1 (hbv 1)-infektion

Publications (2)

Publication Number Publication Date
DK240089D0 DK240089D0 (da) 1989-05-17
DK240089A true DK240089A (da) 1989-11-19

Family

ID=6354610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK240089A DK240089A (da) 1988-05-18 1989-05-17 Fremgangsmaade til udvinding af et proeveantigen til diagnosticering af infektion med bovint herpesvirus

Country Status (4)

Country Link
EP (1) EP0342564B1 (da)
AT (1) ATE101196T1 (da)
DE (2) DE3816885A1 (da)
DK (1) DK240089A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003543A1 (de) * 1990-02-06 1991-08-08 Orpegen Med Molekularbioforsch Verfahren zur abreicherung von viren in loesungen und zur bestimmung der abreicherungsrate von viren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2033946C2 (de) * 1970-07-08 1983-05-26 Bayer Ag, 5090 Leverkusen Lebendimpfstoff gegen infektiöse pustulöse Vulvovaginitis [IPV] und infektiöse bovine Rhinotracheitis [IBR]

Also Published As

Publication number Publication date
ATE101196T1 (de) 1994-02-15
DE3816885A1 (de) 1989-11-30
DE58906864D1 (de) 1994-03-17
DK240089D0 (da) 1989-05-17
EP0342564A2 (de) 1989-11-23
EP0342564A3 (de) 1991-01-09
EP0342564B1 (de) 1994-02-02

Similar Documents

Publication Publication Date Title
GR3019112T3 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic.
LU91396I2 (fr) "La combinaison de la protéine L1 recombinante du papillomavirus humain de types 6,11,16 et 18" -Gardasil/Silgard
NO871313D0 (no) Fremgangsmaate for fremstilling av virusvaksine.
DK672789D0 (da) Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme
DE69334299D1 (de) Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine
OA09889A (en) Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus.
DE69434954D1 (de) Peptide zum Induzieren einer Antwort der zytotoxischen T-Lymphozyten gerichtet gegen das Hepatitis-B-Virus
EP0616535A4 (en) PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
Fujinami et al. Failure to cleave measles virus fusion protein in lymphoid cells. A possible mechanism for viral persistence in lymphocytes
SE9202968D0 (sv) New peptides, diagnostic antigens, use thereof, vaccines and medicaments
DK240089D0 (da) Fremgangsmaade til udvinding af et proeveantigen til diagnosticering af infektion med bovint herpesvirus
ES2132204T3 (es) Procedimiento de preparacion de antigenos y de vacunas del virus de la hepatitis a (hav).
GR3007856T3 (da)
ES2100185T3 (es) Secuencia de adnc y deteccion del virus de la hepatitis c.
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
CA1289881C (en) Vaccine against herpes simplex
Sugamura et al. Expression of Target Antigen for Epstein‐Barr Virus‐Specific Cytotoxic T Cells on BJAB Cells Freshly Infected with EBV
Schultz et al. Bovine vaccines: which work best and what's new or coming?
Mikhailov et al. The influence of gamma irradiation on hepatitis B virus components and delta antigen.
Coursaget et al. Clinical Research: Incidence and Chronicity of Non-A, Non-B Hepatitis in Burn Patients
SU1834289A1 (ru) Способ концентрирования вирусов

Legal Events

Date Code Title Description
ATS Application withdrawn